Cancer Research

Vanderbilt University may nominate one candidate for the Mary Kay Foundation Translational Cancer Research Grant program for 2016. Read More

New “tumor in a dish” technology is poised to assess rapidly how effective specific anticancer cocktails will be on an individual’s cancer before chemotherapy begins. Read More

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators. Read More

The V Scholar Award supports young tenure-track faculty to begin their cancer research career. Read More

Vanderbilt may nominate one candidate for the V Foundation 2015 Translational Grant. Read More

A specific gene expression profile represents a novel, biologically relevant “signature” for identifying colon cancers with high risk of metastatic recurrence, Vanderbilt researchers have found. Read More

Melanoma is the most lethal form of skin cancer, with high mortality rates. While new drugs have been approved to treat the disease, patients nearly always develop resistance to the therapies and the cancer advances. Read More

The activity of a certain factor in immune cells is essential for an anti-tumor response, emphasizing the need to consider the effects of anti-cancer therapies on immune cells. Read More

A non-invasive imaging tool could test potential cancer therapies quickly to personalize therapy for patients. Read More

Vanderbilt researchers have identified a new target for blocking breast cancer metastasis. Read More

The protein MTBP is overexpressed in an aggressive type of breast cancer, and it regulates another protein implicated in many cancer types, suggesting that it may be a good target for new therapeutics. Read More

Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer. Read More

A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies. Read More

Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread. Read More

A group of Vanderbilt researchers has used laser technology and a custom-built multiphoton microscope to distinguish breast cancer subtypes and determine if specific therapies are working against the cancer cells in as little as two days. Read More

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments. Read More

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor. Read More

Rose Vick, MSN, instructor at Vanderbilt University School of Nursing, has blood drawn during Cancer Prevention Study-3 enrollment on April 25. Sponsored by the American Cancer Society, the goal of the nationwide study is to examine a wide spectrum of lifestyle, behavioral, environmental and genetic risk… Read More

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified. Read More

(image courtesy of Monroe Carell Jr. Children's Hospital at Vanderbilt) All funds raised at the Cooper Trooper Pumpkin Patch, open during the month of October, will benefit the Cooper Trooper Foundation Fund in Childhood Cancer Research at the Monroe Carell Jr. Children’s Hospital at Vanderbilt. The pumpkin patch… Read More